Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Christensen (Odense, Denmark), S. Svane (Odense, Denmark), H. Madsen (Odense, Denmark). Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study. 1800

Member's Comments

No comment yet.

Related content which might interest you: PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines Source: Annual Congress 2010 - State of the art imaging Year: 2010 Patient perspectives and experience on the diagnostic pathway of lung cancer – a qualitative study Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care Year: 2018 Feasibility study of cryobiopsy for practical pathological diagnosis including immunohistochemical assessment of primary lung cancer Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 A study of design an original questionnaire for evaluating risks of lung cancer Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules Year: 2018 Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 A basic prediction model with clinical parameters to diagnose lung cancer. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 A novel proteomic technique to identify new diagnostic biomarkers for malignant pleural mesothelioma: a feasibility study. Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021 The ALA/ATS implementation guide on lung cancer screening Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 Combining exhaled-breath analysis data with clinical parameters to improve the diagnosis of lung cancer Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 A usefulness of 25G core needles for immunohistochemistry and molecular testing in lung cancer patients – a feasibility study Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration Year: 2019 A preliminary study on targeted therapies in advanced lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Individualised field testing is a useful tool to evaluate difficult asthma. Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017 Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013 Development and validation of a simple tool for clinical assessment of patients treated with home NIV: The S3-NIV questionnaire Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017